Endo International Plc. Watchdog Report ™ ENDP (NASDAQ Global) | CIK:1593034 | Ireland | SEC llings The new model for duciary analysis Oct 1, 2021 Jan 1, 2020 Jan 1, 2016 RECENT PERIOD HISTORICAL PERIOD Key Facts 10-Q led on Aug 6, 2021 for period ending Jun 2021 Business address: Dublin 4, Ireland Reporting Irregularities RECENT HISTORICAL Industry: Pharmaceutical Preparation Manufacturing (NAICS 325412) Financial Restatements SEC ler status: Large Accelerated Filer as of Jun 2021 Index member: S&P 600, Russell 2000 Revisions Market Cap: $757m as of Sep 30, 2021 Out of Period Adjustments Annual revenue: $2.9b as of Dec 31, 2020 Late Filings Corporate Governance Impairments CEO: Blaise Coleman since 2020 Changes in Accounting Estimates CFO: Mark Bradley since 2020 Disclosure Controls 1st level Internal Controls Board Chairman: Paul V. Campanelli since 2019 Critical / Key Audit Matters Audit Committee Chair: NOT AVAILABLE 2nd level Anomalies in the Numbers RECENT HISTORICAL Auditor: PricewaterhouseCoopers LLP since 2014 Benford's Law Outside Counsel (most recent): Dechert LLP 3rd level Beneish M-Score Accounting Disclosure Complexity SEC Reviewer: Mary Beth Breslin 4th level Securities & Exchange Commission Concerns RECENT HISTORICAL SEC Oversight SEC Letters to Management Revenue Recognition Non-GAAP Measures Litigation & External Pressures RECENT HISTORICAL Signicant Litigation Securities Class Actions Shareholder Activism Watchdog Research, Inc., offers both individual and group subscriptions, Cybersecurity data feeds and/or custom company reports to our subscribers. Management Review Subscribe: We have delivered 300,000 public company reports to over RECENT HISTORICAL 27,000 individuals, from over 9,000 investment rms and to 4,000+ public CEO Changes company corporate board members. CFO Changes How to analyze this company's Watchdog Insider Sales Report? Skip to the last page Pledged Securities Information in this report is effective Oct 1, 2021 and is taken from the Mergers & Acquisitions company's public nancial and regulatory lings. Latest ling 10-Q led Sales of Assets 08/06/2021. Over 75 accounting and data analysts scrutinize and review crucial information, footnotes, disclosures, etc., from these lings. Material Auditor Assessment facts are captured and processed using our proprietary methods which RECENT HISTORICAL identify key risk factors our readers need to know. Each Watchdog Report Auditor Changes represents 30 or more hours of analysis and processing. Auditor Experience Accounting and nancial disclosure data from Audit Analytics. Auditor Tenure Executive compensation data from Shore Group and Intrinio. Data from Sharadar. Audit Fees Data from Barchart via Quandl. Non-Audit Fees Data from Exchange Data International via Quandl. Watchdog Research, Inc. • www.watchdogresearch.com • [email protected] • (855) 820-6272 Overview Reporting Irregularities Anomalies in the Numbers SEC Concerns Litigation & External Pressures Management Review Auditor Assessment Peer Group Overview Price and Volume History This graph shows the price and trading history for Endo. Warning signs and red ags are marked on the graph according to their disclosure dates. 1 Aug 6, 2021 - Change in Accounting Estimates 20 Aug 14, 2020 - Lawsuit: Self-Insured Schools of California v. Jazz Pharmaceuticals PLC … 2 Aug 5, 2021 - Lawsuit: Value Drug Company v. Takeda Pharmaceuticals USA Inc et al 21 Aug 6, 2020 - Change in Accounting Estimates 3 Jun 25, 2021 - Lawsuit: FWK Holdings LLC et al v. Takeda Pharmaceutical Company Ltd… 22 Jul 13, 2020 - Lawsuit: Government Employees Health Association Inc v. Jazz Pharmac… 4 May 7, 2021 - Change in Accounting Estimates 23 Jun 19, 2020 - Lawsuit: Albiges v. Endo International PLC et al 5 Feb 26, 2021 - Impairment 24 Jun 19, 2020 - Securities Class Actions Lawsuit: Albiges v. Endo International PLC et al 6 Feb 26, 2021 - Change in Accounting Estimates 25 May 7, 2020 - Change in Accounting Estimates 7 Feb 26, 2021 - Critical / Key Audit Matters 26 Feb 26, 2020 - Impairment 8 Feb 26, 2021 - Critical / Key Audit Matters 27 Feb 26, 2020 - Impairment 9 Feb 26, 2021 - Critical / Key Audit Matters 28 Feb 26, 2020 - Impairment 10 Jan 25, 2021 - Lawsuit: Federal Trade Commission v. Endo Pharmaceuticals Inc et al 29 Feb 26, 2020 - Change in Accounting Estimates 11 Dec 16, 2020 - Lawsuit: In re Xyrem (Sodium Oxybate) Antitrust Litigation 30 Feb 26, 2020 - Critical / Key Audit Matters 12 Dec 7, 2020 - Lawsuit: Par Pharmaceutical Inc et al v. Eagle Pharmaceuticals Inc 31 Feb 26, 2020 - Critical / Key Audit Matters 13 Dec 7, 2020 - Lawsuit: Par Pharmaceutical Inc et al v. Aurobindo Pharma USA Inc et al 32 Feb 26, 2020 - Critical / Key Audit Matters 14 Dec 7, 2020 - Lawsuit: Par Pharmaceutical Inc et al v. Dr Reddy's Laboratories Inc et al 33 Feb 25, 2020 - Insider Sale 15 Nov 6, 2020 - Change in Accounting Estimates 34 Feb 21, 2020 - Lawsuit: In Re National Prescription Opiate Litigation 16 Nov 6, 2020 - Disclosure Controls 35 Feb 19, 2020 - Change in CEO 17 Oct 19, 2020 - Mergers & Acquisitions 36 Feb 19, 2020 - Change in CFO 18 Sep 16, 2020 - Lawsuit: Hollman v. Jazz Pharmaceuticals PLC et al 37 Feb 6, 2020 - Lawsuit: In Re Zantac (Ranitidine) Products Liability Litigation 19 Aug 18, 2020 - Lawsuit: In re Seroquel XR Extended Release Quetiapine Fumarate Antitr… 38 Dec 20, 2019 - Lawsuit: Reliable Pharmacy et al v. Actavis Holdco US Inc et al Watchdog Research, Inc. • www.watchdogresearch.com • [email protected] • (855) 820-6272 39 Oct 28, 2019 - Lawsuit: Blue Cross Blue Shield of Michigan et al v. Endo Pharmaceutica… 81 Jun 29, 2017 - Lawsuit: Lewis v. Purdue Pharma LP et al 40 Oct 5, 2019 - Lawsuit: Rhodes et al v. Rhodes Technologies Inc et al 82 Jun 12, 2017 - Lawsuit: Noden Pharma DAC v. Anchen Pharmaceuticals Inc et al 41 Aug 8, 2019 - Lawsuit: In re Sitagliptin Phosphate 708 & 921 Patent Litigation 83 May 4, 2017 - Lawsuit: Celgene Corporation v. Par Pharmaceutical Inc et al 42 May 9, 2019 - Change in Accounting Estimates 84 Apr 17, 2017 - Lawsuit: State of Mississippi v. Endo Pharmaceuticals Inc 43 Apr 18, 2019 - Lawsuit: Par Pharmaceutical Inc et al v. Amneal Pharmaceuticals Comp… 85 Mar 31, 2017 - Lawsuit: Public Employees' Retirement System of Mississippi v. Endo In… 44 Apr 4, 2019 - Insider Sale 86 Mar 31, 2017 - Securities Class Actions Lawsuit: Public Employees' Retirement Syste… 45 Mar 4, 2019 - Lawsuit: Athenex Pharma Solutions LLC et al v. Azar II et al 87 Mar 27, 2017 - Lawsuit: Boone County Commission v. AmerisourceBergen Drug Corpora… 46 Feb 13, 2019 - Lawsuit: United HealthCare Services Inc v. Actavis Holdco US Inc et al 88 Mar 1, 2017 - Impairment 47 Dec 20, 2018 - Lawsuit: Par Pharmaceutical Inc et al v. Amneal Pharmaceuticals of Ne… 89 Mar 1, 2017 - Impairment 48 Dec 18, 2018 - Lawsuit: City and County of San Francisco et al v. Purdue Pharma LP et al 90 Feb 3, 2017 - Lawsuit: The State of California et al v. Allergan plc et al 49 Oct 11, 2018 - Lawsuit: Par Pharmaceutical Inc et al v. Sandoz Inc 91 Jan 23, 2017 - Lawsuit: Federal Trade Commission v. Allergan plc et al 50 Sep 25, 2018 - Lawsuit: Marion Diagnostic Center LLC et al v. McKesson Corporation et… 92 Dec 23, 2016 - Lawsuit: In re Propranolol Antitrust Litigation 51 Aug 14, 2018 - Insider Sale 93 Dec 22, 2016 - Change in CFO 52 Aug 13, 2018 - Lawsuit: Athenex Pharma Solutions LLC et al v. Par Pharmaceutical Inc … 94 Nov 18, 2016 - Lawsuit: Aptalis Pharma Canada ULC et al v. Par Pharmaceutical Inc 53 Aug 3, 2018 - Lawsuit: Humana Inc v. Actavis Elizabeth LLC et al 95 Nov 8, 2016 - Disclosure Controls 54 Aug 2, 2018 - Lawsuit: American Resources Insurance Company Inc v. Purdue Pharma L… 96 Nov 7, 2016 - Lawsuit: Shasha v. Endo International PLC et al 55 Jun 22, 2018 - Lawsuit: Ahold USA Inc et al v. Actavis Holdco US Inc et al 97 Nov 7, 2016 - Securities Class Actions Lawsuit: Shasha v. Endo International PLC et al 56 Jun 15, 2018 - Lawsuit: In Re Zetia Ezetimibe Antitrust Litigation 98 Oct 26, 2016 - Lawsuit: Endo Pharmaceuticals Inc et al v. Federal Trade Commission 57 May 31, 2018 - Lawsuit: Par Pharmaceutical Inc et al v. Eagle Pharmaceuticals Inc 99 Oct 21, 2016 - Change in CFO 58 May 16, 2018 - Lawsuit: In re Novartis and Par Antitrust Litigation 100 Oct 17, 2016 - SEC letters to management 59 Apr 26, 2018 - Mergers & Acquisitions 101 Sep 29, 2016 - Lawsuit: Hospira Inc v. Par Sterile Products LLC 60 Feb 27, 2018 - Impairment 102 Sep 28, 2016 - Change in CEO 61 Feb 27, 2018 - Impairment 103 Sep 23, 2016 - Lawsuit: IMPAX Laboratories Inc et al v. Par Pharmaceutical Inc 62 Feb 27, 2018 - Impairment 104 Aug 9, 2016 - Disclosure Controls 63 Feb 27, 2018 - Impairment 105 Aug 5, 2016 - Lawsuit: In Re Generic Pharmaceuticals Pricing Antitrust Litigation 64 Feb 27, 2018 - Disclosure Controls 106 Jul 27, 2016 - Lawsuit: Fresenius Kabi USA LLC v. Par Sterile Products LLC et al 65 Jan 22, 2018 - Lawsuit: The Kroger Co et al v. Actavis Holdco US Inc et al 107 Jun 30, 2016 - Lawsuit: Horizon Therapeutics LLC v. Par Pharmaceutical Inc 66 Jan 16, 2018 - Lawsuit: Columbiana County Board of County Commissioners v. Ameriso… 108 May 25, 2016 - Lawsuit: Friedman v. Endo International plc et al 67 Dec 13, 2017 - Lawsuit: County of San Joaquin et al v. Purdue Pharma LP et al 109 May 25, 2016 - Securities Class Actions Lawsuit: Friedman v. Endo International plc et al 68 Dec 12, 2017 - Lawsuit: Dayton v. Purdue Pharma LP et al 110 May 6, 2016 - Disclosure Controls 69 Nov 14, 2017 - Lawsuit: Pelletier v. Endo International PLC et al 111 May 6, 2016 - Lawsuit: Endo Pharmaceuticals Inc v. Impax Laboratories Inc 70 Nov 14, 2017 - Securities Class Actions Lawsuit: Pelletier v. Endo International PLC et al 112 Mar 30, 2016 - Lawsuit: Federal Trade Commission v.